| Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
| Absorption |
90.0 |
% |
90 |
% |
PO, oral; |
DRUGBANK |
| Bioavailability |
23.0 |
% |
23 |
% |
PO, oral; |
DRUGBANK |
Bioavailability |
5.0 |
% |
5 |
% |
PO, oral; Raceme L; |
DRUGBANK |
| T Max |
1.3 |
h |
1-1.5 |
h |
PO, oral; Raceme L; |
DRUGBANK |
| Clearance |
0.40 |
L/h/kg |
0.4 |
l/h/kg |
intravenous injection, IV; |
DRUGBANK |
Clearance |
0.005000 |
L/h/kg |
0.005 |
l/h/kg |
Renal clearance; |
DRUGBANK |
Clearance |
0.40 |
L/h/kg |
6.67 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
| Volume of Distribution |
2.7 |
L/kg |
2.65 |
L/kg |
intravenous injection, IV; |
DRUGBANK |
Volume of Distribution |
2.7 |
L/kg |
2.65 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
| Half-life |
2.2 |
h |
~2.2 |
h |
terminal half-life; |
DRUGBANK |
Half-life |
3.9 |
h |
3.8-3.9 |
h |
different study; |
DRUGBANK |
Half-life |
6.0 |
h |
5.96 |
h |
intravenous injection, IV; |
DRUGBANK |
Half-life |
5.7 |
h |
5.69 |
h |
PO, oral; |
DRUGBANK |
Half-life |
8.0 |
h |
8 |
h |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
| Toxicity LD50 |
190.0 |
mg/kg |
190.0 |
mg/kg |
PO, oral; mouse; |
T3DB |
| Eliminate Route |
90.0 |
% |
90 |
% |
Urinary excretion; |
DRUGBANK |
Eliminate Route |
3.3 |
% |
3.3 |
% |
Faeces excretion; |
DRUGBANK |
| Protein Binding |
13.5 |
% |
12-15 |
% |
|
DRUGBANK |
Protein Binding |
15.2 |
% |
15.2±5.2 |
% |
Children; |
DRUGBANK |
Protein Binding |
16.2 |
% |
16.2±1.1 |
% |
adults; |
DRUGBANK |